☆ 4.6 Letter

Intervention strategies for multi-vessel disease in patients with ST-segment elevation myocardial infarction: A meta-analysis of randomized trials

INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY

Volume 179, Issue -, Pages 225-227

Publisher

ELSEVIER IRELAND LTD

DOI: 10.1016/j.ijcard.2014.11.063

Keywords

Percutaneous coronary intervention; Culprit-vessel only PCI; Complete revascularization; Multi-vessel disease; STEMI

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Meta-Analysis Comparing Culprit-Only Versus Complete Multivessel Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction

Waqas Ullah, Salman Zahid, Nayab Nadeem, Smitha Gowda, Samavia Munir, Sameer Saleem, M. Chadi Alraies, Mahboob Alam, David L. Fischman

Summary: In patients with STEMI, compared to COR, MVR may be significantly associated with a reduction in major adverse cardiovascular events, angina, and the need for revascularization.

AMERICAN JOURNAL OF CARDIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Percutaneous coronary intervention using new-generation drug-eluting stents versus coronary arterial bypass grafting in stable patients with multi-vessel coronary artery disease: From the CREDO-Kyoto PCI/CABG registry Cohort-3

Hiroki Watanabe, Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, Eri Kato, Yukiko Matsumura, Kenji Nakatsuma, Yasuaki Takeji, Hidenori Yaku, Erika Yamamoto, Yugo Yamashita, Yusuke Yoshikawa, Masayuki Fuki, Kyohei Yamaji, Natsuhiko Ehara, Hiroki Sakamoto, Kazuaki Imada, Takeshi Tada, Ryoji Taniguchi, Ryusuke Nishikawa, Tomohisa Tada, Takashi Uegaito, Tatsuya Ogawa, Miho Yamada, Teruki Takeda, Hiroshi Eizawa, Nobushige Tamura, Keiichi Tambara, Satoru Suwa, Manabu Shirotani, Toshihiro Tamura, Moriaki Inoko, Junichiro Nishizawa, Masahiro Natsuaki, Hiroshi Sakai, Takashi Yamamoto, Naoki Kanemitsu, Nobuhisa Ohno, Katsuhisa Ishii, Akira Marui, Hiroshi Tsuneyoshi, Yasuhiko Terai, Shogo Nakayama, Kazuhiro Yamazaki, Mamoru Takahashi, Takashi Tamura, Jiro Esaki, Shinji Miki, Tomoya Onodera, Hiroshi Mabuchi, Yutaka Furukawa, Masaru Tanaka, Tatsuhiko Komiya, Yoshiharu Soga, Michiya Hanyu, Kenji Ando, Kazushige Kadota, Kenji Minatoya, Yoshihisa Nakagawa, Takeshi Kimura

Summary: This study compared the effectiveness of percutaneous coronary intervention (PCI) using new-generation drug-eluting stents (DES) with coronary artery bypass grafting (CABG) in patients with multi-vessel coronary artery disease. The results showed that, compared to CABG, PCI for coronary revascularization was associated with an increased long-term risk of major cardiovascular events.

PLOS ONE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock

Jing Wu, Yonggang Wang, Chenguang Li, Honglei Ji, Wenyi Zhao, Qian Tong, Mingyou Zhang

Summary: The frequency of multivessel PCI for STEMI with and without cardiogenic shock is declining. Multivessel PCI is associated with worse in-hospital outcomes for STEMI with cardiogenic shock but not for STEMI without cardiogenic shock.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Staged revascularization vs. culprit-only percutaneous coronary intervention for multivessel disease in elderly patients with ST-segment elevation myocardial infarction

Jiachun Lang, Chen Wang, Le Wang, Jingxia Zhang, Yuecheng Hu, Huajun Sun, Hongliang Cong, Yin Liu

Summary: Staged PCI is superior to culprit-only PCI in elderly patients with STEMI and MVD.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Multivessel versus Culprit-Only Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome

Tobias F. S. Pustjens, Marijke J. C. Timmermans, Saman Rasoul, Arnoud W. J. van't Hof

Summary: The study found that NSTE-ACS patients with MVD undergoing MV-PCI and CO-PCI had similar mortality rates at long-term follow-up, but the MV-PCI group showed improved event-free survival in terms of fewer coronary reinterventions.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial

Zardasht Oqab, Vijay Kunadian, David A. Wood, Robert F. Storey, Sunil V. Rao, Roxana Mehran, Natalia Pinilla-Echeverri, Thenmozhi Mani, Robert H. Boone, Saleem Kassam, Matthias Bossard, Samer Mansour, Warren Ball, Matthew Sibbald, Nicholas Valettas, Raul Moreno, Philippe Gabriel Steg, John A. Cairns, Shamir R. Mehta

Summary: In the COMPLETE trial, the strategy of complete revascularization reduced the risk of major cardiovascular events in both diabetic and non-diabetic STEMI patients, with consistent results.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials for Multivessel PCI Versus Culprit Artery Only PCI in STEMI Without Cardiogenic Shock

Devesh Rai, Muhammad Waqas Tahir, Dhrubajyoti Bandyopadhyay, Medhat Chowdhury, Adnan Kharsa, Venkata Satish Pendala, Hammad Ali, Srihari S. Naidu, Bipul Baibhav

Summary: Recent studies suggest that in STEMI patients without cardiogenic shock, multivessel PCI may be beneficial compared to culprit-only PCI, reducing the risk of cardiac mortality, reinfarction, repeat revascularization, and MACE.

CURRENT PROBLEMS IN CARDIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Multivessel vs. culprit-only percutaneous coronary intervention strategy in older adults with acute myocardial infarction

Claudio Montalto, Nuccia Morici, Aung Myat, Gabriele Crimi, Giuseppe De Luca, Irene Bossi, Adam de Belder, Stefano Savonitto, Stefano De Servi

Summary: In older adults with acute myocardial infarction, a strategy of multi-vessel percutaneous coronary intervention (MV-PCI) for complete revascularization is associated with better survival and lower risk of adverse clinical events compared to a strategy of culprit-vessel (CV) PCI.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

The optimal timing for non-culprit percutaneous coronary intervention in patients with multivessel coronary artery disease: A pairwise and network meta-analysis of randomized trials

Yujia Feng, Shu Li, Sihan Hu, Jing Wan, Hua Shao

Summary: This study suggests that complete revascularization should be performed in STEMI patients with multivessel coronary artery disease, and complete revascularization at the index procedure is superior to staged revascularization in reducing the risk of MACE events.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Angiography versus FFR guided complete revascularization versus culprit-only revascularization for patients presenting with STEMI: Network meta-analysis

Yoshiyuki Okuya, Kavita Gohil, Issam D. Moussa

Summary: This study compared the outcomes of different revascularization strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing primary percutaneous coronary intervention. The results showed that angiography-guided complete revascularization or fractional flow reserve-guided complete revascularization were associated with better outcomes compared to culprit-only revascularization. Angiography-guided complete revascularization was ranked as the best strategy for reducing major adverse cardiac events, mortality, recurrent myocardial infarction, and unplanned revascularization.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Long-Term Outcomes of Single-Vessel Percutaneous Coronary Intervention on Culprit Vessel vs. Multivessel Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Multivessel Coronary Artery Disease

Tianyu Li, Sida Jia, Yue Liu, Yi Yao, Ying Song, Xiaofang Tang, Xueyan Zhao, Runlin Gao, Yuejin Yang, Bo Xu, Zhan Gao, Jinqing Yuan

Summary: This study compared the long-term prognosis between single-vessel PCI (SV-PCI) and multivessel PCI (MV-PCI) in patients with multivessel coronary artery disease (MV-CAD) presenting with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). The results showed no significant difference in the incidence of major adverse cardiovascular and cerebrovascular events (MACCE) at 2 years between SV-PCI and MV-PCI groups, indicating that MV-PCI is not superior to SV-PCI in terms of long-term MACCE in NSTE-ACS patients with MV-CAD.

CIRCULATION JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI

Benjamin E. Peterson, Deepak L. Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Rebecca A. Juliano, Lixia Jiao, Ralph T. Doyle, Craig Granowitz, C. Michael Gibson, Duane Pinto, Robert P. Giugliano, Matthew J. Budoff, Jean-Claude Tardif, Subodh Verma, Christie M. Ballantyne

Summary: Icosapent Ethyl significantly reduces the risk of recurrent cardiovascular events in patients with elevated triglycerides and a history of prior percutaneous coronary intervention.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Comparison of long-term outcomes of complete vs. incomplete revascularization in elderly patients (& GE;75 years) with acute coronary syndrome and multi-vessel disease undergoing percutaneous coronary intervention

Yu-Ying Lu, Chen-Hung Lee, Chun-Chi Chen, Dong-Yi Chen, Ming-Yun Ho, Jih-Kai Yeh, Yu-Chang Huang, Chieh-Yu Chang, Chao-Yung Wang, Shang-Hung Chang, I-Chang Hsieh, Ming-Jer Hsieh

Summary: This study evaluated the revascularization strategy for elderly ACS patients with MVD. The patients were divided into CR and IR groups based on angiography. The three-year follow-up results showed that CR was associated with lower MACE risk compared to IR, especially in STE-ACS patients. Therefore, CR can achieve better long-term outcomes in elderly ACS patients.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Multivessel vs. Culprit Vessel-Only Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction in Patients With Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis

Bingquan Xiong, Huiping Yang, Wenlong Yu, Yunjie Zeng, Yue Han, Qiang She

Summary: There may be no significant benefit for patients with ST-segment elevation myocardial infarction complicating cardiogenic shock treated with multivessel percutaneous coronary intervention compared with culprit vessel-only PCI, and the risk of developing acute renal failure increases.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

STEMI patients receiving percutaneous coronary intervention for a culprit lesion with coronary artery bifurcation-efficacy and safety of the jailed semi-inflated balloon

Tzu-Hsiang Lin, Kuan-Ju Chen, Yu-Cheng Hu, Keng-Hao Chang, Chih-Hung Lai, Tsun-Jui Liu, Wen-Lieng Lee, Chieh-Shou Su

Summary: This study aimed to evaluate the efficacy and safety of the 'jailed semi-inflated balloon technique' (JSIBT) for side branch (SB) protection in STEMI patients undergoing emergent percutaneous coronary intervention. The use of JSIBT provided better SB protection and had a similar rate of SB complications compared with those using or not using SB wire.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Semaglutide for weight loss and cardiometabolic risk reduction in overweight/obesity

Adriana C. Mares, Saurav Chatterjee, Debabrata Mukherjee

Summary: Obesity is associated with increased risk of cardiovascular disease. Semaglutide is a recently approved drug for chronic weight management in adults with obesity or overweight. It offers a new treatment option in conjunction with a weight management program.

CURRENT OPINION IN CARDIOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

High Flow Nasal Cannula Oxygenation Successfully Used as Bridge Therapy for Systemic Thrombolysis in COVID-19 Associated Intermediate-high Risk Pulmonary Embolism

Maria F. Aguilar-Piedras, Mateo Porres-Aguilar, Debabrata Mukherjee, Guillermo Cueto-Robledo, Ernesto Roldan-Valadez, Patricio A. Tapia-Vargas

Summary: The risk of venous thromboembolism in COVID-19 patients is increasing, especially in severe cases. Individualized treatment is crucial for patients with intermediate high, high-risk PE.

CURRENT PROBLEMS IN CARDIOLOGY (2022)

Add to Collection

Editorial Material Peripheral Vascular Disease

Optimal Treatment of Tapered Coronary Artery Lesions

Chandni Vashee, Adriana Mares, Angelica Lehker, Debabrata Mukherjee

Summary: The success of PCI is defined by post-procedure angiographic outcomes, procedural events, and longer-term clinical outcomes. Stenting long and complex lesions increases the risk of stent thrombosis and restenosis even in the long term. Tapered lesions in the target coronary artery lesion can pose challenges during PCI and affect the outcomes.

ANGIOLOGY (2023)

Add to Collection

Review Peripheral Vascular Disease

Epidemiology, Pathophysiology, and Management of Coronary Artery Disease in the Elderly

Kahtan Fadah, Aimee Hechanova, Debabrata Mukherjee

Summary: Elderly patients over the age of 75 years are highly susceptible to coronary artery disease (CAD) due to age being an important risk factor for atherosclerosis and a predictor of poorer outcomes. CAD is a major cause of mortality and morbidity in this population. Concerns about functional frailty, comorbidities, and patient preference for conservative or no treatment have led to a reduced interest in prospective studies in this high-risk group. This review provides an overview of the epidemiology, pathophysiology, and management of CAD in older adults.

INTERNATIONAL JOURNAL OF ANGIOLOGY (2022)

Add to Collection

Article Peripheral Vascular Disease

Low-Dose Alteplase versus Conventional Anticoagulation to treat Submassive Pulmonary Embolism in Hispanic Patients

Emily Zientek, Kelsey Talkington, Joshua Gardner, Yi Guo, Debabrata Mukherjee, Manu Rajachandran, Tariq S. Siddiqui, Nils P. Nickel

Summary: This study aims to explore the use of low-dose tissue plasminogen activator (tPA) in Hispanic patients with submassive pulmonary embolism (PE). The results showed that compared to patients treated with heparin alone, those who received low-dose tPA had significantly shorter hospital stays. The study also found no clinically relevant bleeding complications in the low-dose tPA group.

INTERNATIONAL JOURNAL OF ANGIOLOGY (2023)

Add to Collection

Review Peripheral Vascular Disease

Reduced-Dose Thrombolysis in Acute Pulmonary Embolism A Systematic Review

Adrian Rojas Murguia, Debabrata Mukherjee, Chandra Ojha, Manu Rajachandran, Tariq S. Siddiqui, Nils P. Nickel

Summary: Pulmonary embolism (PE) is a significant cause of mortality, particularly in cancer patients. Although thrombolysis has shown efficacy in treating acute PE, the optimal dosage and infusion rates have not been established. Higher doses of systemic thrombolysis come with an increased risk of major bleeding. However, evidence suggests that low-dose thrombolysis administered via a peripheral vein can effectively accelerate thrombolysis and reduce the risk of major bleeding in acute PE.

ANGIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Proposed new classification for acute coronary syndrome: Acute coronary syndrome requiring immediate reperfusion

Cesar R. R. Zoni, Debabrata Mukherjee, Martha Gulati

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2023)

Add to Collection

Article Peripheral Vascular Disease

Impact of Ablation during Index Hospitalization on All-Cause Mortality in Patients with Typical Atrial Flutter: Insights from National Multicenter Database

Muhammad Amer, Frank H. Annie, Shubash Adhikari, Debabrata Mukherjee

Summary: This study compared the impact of ablation during index hospitalization (IH) on all-cause mortality (ACM) in patients with newly diagnosed typical atrial flutter (tAFL) versus patients without ablation. Using a large database, researchers found that ablation during IH was associated with a significant reduction in mortality at 6, 12, and 36 months of follow-up in patients with tAFL.

INTERNATIONAL JOURNAL OF ANGIOLOGY (2023)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Racial Disparity and Percutaneous Coronary Intervention Outcomes

Debabrata Mukherjee

AMERICAN JOURNAL OF CARDIOLOGY (2023)

Add to Collection

Letter Peripheral Vascular Disease

Letter to the Editor: Reduced-Dose Thrombolysis for Acute Pulmonary Embolism

Adrian Rojas Murguia, Debabrata Mukherjee, Chandra Ojha, Manu Rajachandran, Nils P. Nickel

ANGIOLOGY (2023)

Add to Collection

Article Peripheral Vascular Disease

Prevalence and clinical significance of deep vein thrombosis in Hispanic patients with acute pulmonary embolism

Adrian Rojas Murguia, Swathi Prakash, Fernando Segovia, Fatih Ayvali, Michael Brockman, Sahithi Nadella, Vishwajeet Singh, Alok Kumar Dwivedi, Manu Rajachandran, Debabrata Mukherjee, Nils P. Nickel

Summary: This study retrospectively examined Hispanic patients admitted for acute pulmonary embolism (PE) and found that the presence of concomitant deep vein thrombosis (DVT) was associated with clot burden on chest CT, right heart strain, and 30-day mortality. Among the 391 patients studied, 42.9% had concomitant DVT on admission, and 9.9% died during the 30-day follow-up, with a higher mortality rate among those with concomitant DVT. Proximal DVT independently predicted 30-day mortality, even after adjusting for age, gender, and PE severity index scores. The prevalence of concomitant DVT in Hispanic patients with acute PE was relatively low, but the location of the DVT had significant prognostic relevance.

ANGIOLOGY (2023)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Optimal Management of Femoropopliteal Arterial Disease in Patients With Intermittent Claudication

Debabrata Mukherjee

JACC-CARDIOVASCULAR INTERVENTIONS (2023)

Add to Collection

Letter Hematology

Pulmonary embolism response teams: changing the paradigm in the care for acute pulmonary embolism: reply

Mateo Porres-Aguilar, Rachel P. Rosovsky, David Jimenez, Debabrata Mukherjee, Belinda N. Rivera-Lebron, Scott Kaatz, Javier E. Anaya-Ayala, Carlos Jerjes-Sanchez

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

The Association Between Non-Clinically Apparent Liver Fibrosis and Pulmonary Arterial Hypertension in Hispanic Patients

M. Ammar Kalas, Yacoub Khatab, Gian Galura, Haider Alkhateeb, Debabrata Mukherjee, Hernando Garcia, Marc Zuckerman, Nils Patrick Nickel

Summary: PAH patients with NAFLD may have worse outcomes, and NFS can predict the degree of liver fibrosis and correlate with hemodynamics, functional status, and outcomes.

CARDIOLOGY RESEARCH (2023)

Add to Collection

Review Peripheral Vascular Disease

Factor XI/XIa inhibitors for the prevention and treatment of venous and arterial thromboembolism: A narrative review

Swathi Prakash, Adriana C. Mares, Mateo Porres-Aguilar, Debabrata Mukherjee, Geoffrey D. Barnes

Summary: This review summarizes the key data on the clinical pharmacology of FXI, the latest developments in clinical trials of FXI inhibitors, and describes the efficacy and safety profiles of FXI inhibitors for the prevention of venous and arterial thromboembolism.

VASCULAR MEDICINE (2023)

Add to Collection

No Data Available

Intervention strategies for multi-vessel disease in patients with ST-segment elevation myocardial infarction: A meta-analysis of randomized trials

Journal

Publisher

ELSEVIER IRELAND LTD

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper